Protective Effect of Rivaroxaban Against Amyloid Pathology and Neuroinflammation Through Inhibiting PAR-1 and PAR-2 in Alzheimer’s Disease Mice

Zhihong Bian, Xia Liu, Feng Tian, Haibo Yu, Xiao Hu, Xinran Hu, Yuting Bian, Hongming Sun, Koh Tadokoro, Mami Takemoto,

Journal of Alzheimer s Disease · 2022 · 14 citations · 37 references

Abstract

The present study demonstrates that rivaroxaban can attenuate AD progress and can be a potential choice to prevent AD.

References

37